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ORIGINAL ARTICLE
Temporal Evolution of the PcvCO2–PaCO2/CaO2–CcvO2 
Ratio vs Serum Lactate during Resuscitation in Septic Shock
Shyam Madabhushi1 , Anjan Trikha2 , Rahul K Anand3 , Rashmi Ramachandran4 , Preet M Singh5 , Vimi Rewari6  
Ab s t r Ac t
Background: Lactate as a target for resuscitation in patients with septic shock has important limitations. The PcvCO2–PaCO2/CaO2–CcvO2 
ratio may be used as an alternative for the same. The primary outcome of the study is to evaluate the correlation between serum lactate and 
PcvCO2–PaCO2/CaO2–CcvO2 ratio measured at various time points to a maximum of 24 hours in patients with septic shock [mean arterial pressure 
(MAP) <65 mm Hg]. The secondary outcomes were to study the (1) relationship between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and lactate 
clearance at 6, 12, and 24 hours as compared to the initial serum lactate, (2) to ascertain whether the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the 
arterial lactate levels in the first 24 hours are able to predict mortality at day 28 of enrollment, and (3) to determine whether the PcvCO2–PaCO2/ 
CaO2–CcvO2 ratio and arterial lactate are useful in discriminating survivors from nonsurvivors.
Materials and methods: Thirty patients with sepsis-induced hypotension who were being actively resuscitated were enrolled. Paired arterial 
and central venous blood samples were obtained 0.5 hourly till stabilization of MAP and 6 hourly thereafter for the first 24 hours. Patients were 
followed up to day 28 of enrollment for mortality and organ system failure.
Results: A positive correlation was observed between arterial lactate and PcvCO2–PaCO2/CaO2–CcvO2 ratio at 0, 6, 12, and 18 hours (R = 0.413, 
p = 0.02; R = 0.567, p = 0.001; R = 0.408, p = 0.025; R = 0.521, p = 0.003, respectively). No correlation was seen between PcvCO2–PaCO2/CaO2–
CcvO2 ratio and lactate clearance. The subgroup analysis showed that PcvCO2–PaCO2/CaO2–CcvO2 ratio >1.696 at 24 hours of resuscitation 
predicted 28-day mortality (sensitivity: 80%, specificity 69.2%, area under the receiver operating characteristic curve 0.82).
Conclusion: The PcvCO2–PaCO2/CaO2–CcvO2 ratio and lactate are positively correlated during the first 24 hours of active resuscitation from 
sepsis-induced hypotension, and a threshold of 1.696  mm  Hg/mL/dL at 24  hours significantly differentiates survivors from nonsurvivors 
(CTRI/2017/11/010342).
Keywords: PcvCO2–PaCO2/CaO2–CcvO2 ratio, Resuscitation, Septic shock, Serum lactate.
Indian Journal of Critical Care Medicine (2021): 10.5005/jp-journals-10071-24044
In t r o d u c t I o n
Sepsis has been defined as a dysregulated host response to 
infection.1 Patients with sepsis are frequently admitted to the 
intensive care unit (ICU) for managing hypotension and are 
resuscitated with vasopressors and intravenous crystalloids. The 
Surviving Sepsis Campaign2 recommends resuscitation end points, 
which may be classified as macro- or microcirculatory.3 Arterial 
lactate, a commonly used end point, is considered an imperfect 
marker of anaerobic metabolism in sepsis.4 As an alternative, the 
PcvCO2–PaCO2/CaO2–CcvO2 ratio has been proposed. The shock 
causes a decrease in tissue perfusion and oxygen availability, 
which shifts energy production to anaerobic pathways, leading to a 
decrease in the ratio of aerobic to anaerobic metabolism. To detect 
this shift, the ratio of CO2 production and O2 utilization is measured. 
In a perfectly aerobic system, all CO2 production is derived from 
aerobic glucose oxidation, which leads to a CO2 production: O2 
utilization ratio of 1.0. If anaerobic metabolism increases, the O2 
utilization reduces but the anaerobic production of CO2 continues, 
thereby resulting in an increase in the CO2 production: O2 utilization 
ratio. Since the measurement of the actual CO2 production and 
O2 utilization is not practical in the clinical setting, the PcvCO2–
PaCO2/CaCO2–CcvO2 ratio is used as a surrogate of the same. The 
numerator reflects CO2 production, whereas the denominator 
reflects O2 utilization. In shock, the ratio is expected to increase, 
implying worsening tissue hypoxia. Resuscitation would improve O2 
utilization, which would result in a reduction of the ratio. This ratio 
may be alternatively called the “calculated respiratory quotient.”
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Previous studies that have investigated the utility of the 
PcvCO2–PaCO2/CaO2–CcvO2 ratio have important limitations. 
Some were retrospective in nature5 or included patients after 
attaining resuscitation end points as defined by the Surviving Sepsis 
Campaign guidelines.6 Our study, therefore, is aimed at delineating 
the evolution of the PcvCO2–PaCO2/CaO2–CcvO2 ratio during 
the first 24 hours of resuscitation in patients with sepsis-induced 
hypotension and contrast it with the evolution of arterial lactate.
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AI m s A n d ob j e c t I v e s
The primary objective of the study is to examine the correlation 
between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the arterial 
lactate during the first 24 hours of resuscitation from septic shock. 
The secondary objectives of the study are: (1) to examine the 
correlation between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and 
the lactate clearance within the same time period, (2) to ascertain 
whether the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the arterial 
lactate levels in the first 24 hours are able to predict mortality at day 
28 of enrollment, and (3) to determine whether the PcvCO2–PaCO2/
CaO2–CcvO2 ratio and arterial lactate are useful in discriminating 
survivors from nonsurvivors. A subgroup analysis (survivors and 
nonsurvivors at day 28 of enrollment) of the PcvCO2–PaCO2/CaO2–
CcvO2 ratio and the arterial lactate was also planned.
mAt e r I A l s A n d me t h o d s
Patients
A prospective observational study was designed and conducted 
in two ICUs of a tertiary care hospital in North India. One is 
a 10-bedded mixed medical–surgical ICU and the other is a 
12-bedded level-3 trauma ICU. Patients were recruited from 
September 2016 to June 2018. All adult patients admitted to the 
ICU with sepsis-induced hypotension [defined as mean arterial 
pressure (MAP) <65 mm Hg] and with an arterial and central venous 
catheter were considered for inclusion into the study. Pregnancy, 
patients less than 18 years of age, those who did not have a central 
or arterial line inserted, those in whom resuscitation was aimed 
at supraphysiological targets, and those in whom consent was 
not available were excluded from the study. Flowchart 1 depicts 
the procedure of enrollment of patients in the study. The trial was 
approved by the institutional ethics committee and was registered 
with the Clinical Trials Registry of India (CTRI/2017/11/010342).
Measurements
Paired arterial and central venous samples were drawn from 
enrolled patients to measure lactate and calculate the PcvCO2–
PaCO2/CaO2–CcvO2 ratio. Two sampling intervals were followed. 
To capture the early phase of resuscitation, initially, these paired 
samples were drawn and analyzed at half-hourly intervals till 
stable MAP targets were achieved. Stability was defined as 
MAP >65 mm Hg for more than 15 minutes without escalating 
the doses of vasopressors. A maximum of four such samples was 
permitted (accounting for the first 2  hours). For the remainder 
of the first 24  hours, sampling and measurement were done 
six hourly. Data were entered into a standard format. Clinical 
decision-making and interventions were as per the intensivist in 
charge of the case. Hemoglobin levels were obtained from the 
central laboratory. The following were calculated according to 
standard formulae:
• Ar te r ia l  ox yg e n co nte nt  (C a O2) :  C a O2 (m L O2 /d L)   
= (1.34 × hemoglobin concentration × SaO2) + (0.0031 × PaO2)
• Central venous oxygen content (CcvO2): CcvO2 (mL O2/dL)    
= (1.34 × hemoglobin concentration × ScvO2) + (0.0031 × PaO2)
• Lactate clearance at 6, 12, 18, and 24 hours using arterial lactate 
at enrollment as baseline (lactate T0). Lactate clearance (using 
6 hours as an example): (arterial lactate at T0 - arterial lactate at 
6 hours)/arterial lactate at T0 × 100%
All patients were followed up for 28 days after enrollment or 
death or hospital discharge (whichever was earlier). 
To calculate the sample size, data from a study by Mekontso-
Dessap et  al . 5 were used. The correlation between the 
PcvCO2–PaCO2/CaO2–CcvO2 ratio and the lactate was 0.57. 
Using a two-tailed type-I error of 0.05 and a type-II error of 0.2, 
a sample size of 22 was obtained. We enrolled 30 patients in our 
study.
Statistical Analysis
Patient characteristics and demographic data were described in 
terms of mean and standard deviation (SD) or median and range, 
as applicable. Correlation between the PcvCO2–PaCO2/CaO2–CcvO2 
ratio and lactate and PcvCO2–PaCO2/CaO2–CcvO2 ratio and lactate 
clearance were calculated using the Spearman’s coefficient (p). 
Flowchart 1: Study flow diagram
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Thirteen patients survived to day 28 of enrollment (28-day mortality 
was 56.6%).
The primary outcome of the study was the correlation 
between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the arterial 
lactate at each of the sampling time points. The correlation 
between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the arterial 
lactate was positive and was statistically significant at time 
points 0, 6, 12, and 18 hours. The correlation was strongest at the 
18-hour time point (Table 2). The correlation between the PcvCO2–
PaCO2/CaO2–CcvO2 ratio and the lactate clearance was negative 
but reached significance only at one time point (T =  18  hours; 
p = −0.4448, p = 0.0138) (Table 3).
The study population was divided into survivors and 
nonsurvivors, and data were analyzed to discern differences, if 
any, in the parameters assessed. There was no difference in the 
mean values of hemoglobin and ScvO2 between the survivors 
and nonsurvivors (p >0.05). The PcvCO2–PaCO2/CaO2–CcvO2 ratio 
was higher in nonsurvivors than in survivors at all time points 
except at 1  hour. However, the difference reached a statistical 
significance only at 24 hours (z = −2.879; p = 0.0040) (Table 4). 
Assuming that the PcvCO2–PaCO2/CaO2–CcvO2 ratio remained 
constant between two measurements, the time duration for 
which it remained abnormal (>1) was calculated for differences 
between survivors and nonsurvivors. No such difference was 
found (Student’s t test, p >0.05). Similar calculations were made 
for the arterial lactate between survivors and nonsurvivors 
(Table 5). The median lactate was greater in nonsurvivors than in 
survivors, but the difference reached significance only at 18 and 
24 hours. There was no difference between the time duration for 
Subgroup analysis of these variables between survivors and 
nonsurvivors was done using the Wilcoxon–Mann–Whitney test. 
Sensitivity and specificity of the PcvCO2–PaCO2/CaO2–CcvO2 ratio 
and lactate for predicting mortality were calculated, and receiver 
operating characteristic (ROC) curves were constructed. To analyze 
whether the proportion of patients with calculated thresholds for 
lactate and the PcvCO2–PaCO2/CaO2–CcvO2 ratio were different 
between survivors and nonsurvivors, the Fisher’s exact test was 
used. A p value of <0.05 was considered statistically significant. All 
statistical analyses were performed using Stata (Ver 15.1; StataCorp 
LLC, Texas, USA).
re s u lts
Data from all 30 patients were analyzed which included a total of 186 
samples. Two patients died in the 18–24 hours’ period. Their data 
till the 18-hour mark were collected and analyzed. Eight patients 
were sampled half-hourly beyond the first half hour. The rest of the 
patients had a stable MAP at the end of the first half hour and did 
not need additional half-hourly sampling.
The mean age of the patients was 38 years (SD 17.54; range 
18–77 years). The median time between hospital admission and the 
development of septic shock was 97 hours (range: 2–1116 hours). 
The median time between the identification of hypotension and 
the first paired arterial and central venous sample was 0.5 hours 
(SD 0.298, range 0–1 hours) (Table 1). The main source (suspected 
or proven) of sepsis was respiratory (n = 15; 50%), followed by the 
abdomen (n = 8; 26.67%). The source of sepsis remained unknown 
in two patients. The median length of ICU stay was 15.5  days. 
Table 1: Demographic and disease characteristics
Variable Mean Median SD Maximum Minimum
Age (in years) 38.4 17.54 77 18
Height (in cm)    165.8 cm   6.664 178 155
Weight (in kg) 64.9 10.24 85 40
Time between clinical event and 
hospital arrival (in hours)
38 720 0
Time between hospital admission 
and development of septic shock (in 
hours)
97 1116 2
Time between identification of 
hypotension and first paired sample 
(in hours)
 0.5  0.298 1 0
APACHE II score 20.5 42 7
SOFA at enrollment 10 19 4
Hemoglobin (g/dL)  9.0   1.663 14.3 6.5
ScvO2 (%) 73.1 10.26 89.1 51
Table 2: Correlation between PcvCO2–PaCO2/CaCO2–CcvO2 ratio and 
lactate
Time point Spearman’s rho (ρ) Probability (p) value
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Kaplan–Meier survival estimates [χ2 = 0.70, p = 0.4016 for lactate 
2  mmol/L; χ2 =  0.69, p =  0.4076 for PcvCO2–PaCO2/CaO2–CcvO2 
ratio]. For the thresholds chosen at time point 24 hours, there were 
significant differences in the Kaplan–Meier survival estimates. For 
a lactate of 1.6 mmol/L, the probability of 28-day survival was 26.6 
and 69.2% above and below this threshold, respectively (χ2 = 5.62, 
p =  0.0177) (Fig. 3). For the PcvCO2–PaCO2/CaO2–CcvO2 ratio of 
1.696, the probability of 28-day survival was 25 and 75% above and 
below this ratio, respectively (χ2 = 6.00, p = 0.0143) (Fig. 4).
dI s c u s s I o n
Our results demonstrated a significant positive correlation 
between lactate and the (PcvCO2–PaCO2/CaO2–CcvO2 ratio at 0, 
6, 12, and 18 hours during the first 24 hours of resuscitation after 
sepsis-induced hypotension. Resuscitation attempts to increase 
DO2, which then increases VO2 causing lactate levels to fall. 
Simultaneously, the anaerobic production of CO2 decreases, and 
the PcvCO2–PaCO2/CaO2–CcvO2 ratio falls. This physiology explains 
the positive correlation between these two variables. To the best of 
our knowledge, this is probably the only prospective study that has 
which lactate was elevated (>2  mmol/L) among survivors and 
nonsurvivors (p >0.05).
ROCs were constructed after calculating the thresholds for 
variables predictive of 28-day mortality. The variables considered 
were arterial lactate, venoarterial PCO2 gap, PcvCO2–PaCO2/CaO2–
CcvO2 ratio, ScvO2, and arteriovenous O2 content difference. Of 
these variables, only the arterial lactate and the PcvCO2–PaCO2/
CaO2–CcvO2 ratio had a significant area under the ROC curve 
(AU-ROC). The PcvCO2–PaCO2/CaO2–CcvO2 ratio at 24 hours with a 
value greater than 1.696 mm Hg/mL/dL was predictive of mortality 
with a sensitivity of 80% and a specificity of 69.2%. The AU-ROC was 
0.8205 (95% confidence interval [CI] 0.661–0.979) (Fig. 1). For arterial 
lactate at 24 hours, a value >1.6 mmol/L was predictive of mortality 
at 28 days with a sensitivity of 73.33% and a specificity of 69.23%. 
The AU-ROC was 0.853 (95% CI 0.712–0.915) (Fig. 2).
Using the log-rank test, survival differences were estimated for 
threshold values of both the arterial lactate and PcvCO2–PaCO2/
CaO2–CcvO2 ratio. At time 0, the thresholds chosen were the 
normal values of the variables [1 for PcvCO2–PaCO2/CaO2–CcvO2 
ratio and 2 mmol/L for arterial lactate]. At the 24-hour time point, 
the thresholds chosen were those that were estimated to have the 
best sensitivity and specificity for mortality prediction from the ROC 
curves. Accordingly, these values were 1.696 for the PcvCO2–PaCO2/
CaO2–CcvO2 ratio and 1.6 mmol/L for the arterial lactate. For the 
thresholds chosen at enrollment, there were no differences in the 
Table 3: Correlation between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and 
the lactate clearance
Time point Spearman’s rho (ρ) Probability value (p)






Table 4: PcvCO2–PaCO2/CaO2–CcvO2 ratio in survivors and nonsurvivors
Time point Wilcoxon rank sum Probability value (p)
0 −0.984 0.3253
0.5 hour −1.611 0.1071
1 hour  0.745 0.4561




Table 5: Arterial lactate in survivors and nonsurvivors








Fig. 1: Receiver operating characteristic curve for PcvCO2–PaCO2/CaO2–
CcvO2 ratio at 24 hours for predicting 28-day mortality
Fig. 2: Receiver operating characteristic curve for arterial lactate at 
24 hours for predicting 28-day mortality
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PcvCO2–PaCO2/CaO2–CcvO2 ratio to predict the evolution of lactate. 
Their patient population included those that had normalized their 
ScvO2 and MAP. Their study showed correlation between the 
initial lactate and the PcvCO2–PaCO2/CaO2–CcvO2 ratio (R = 0.73, 
p <0.001). Although this correlation is higher than the correlation 
obtained in our study, this could be due to the fact that samples 
were obtained only after normalization of ScvO2 and MAP. 
In terms of secondary outcomes, both the PcvCO2–PaCO2/
CaO2–CcvO2 ratio and the arterial lactate are predictive of mortality. 
For this, Kaplan–Meier curves were calculated at two points: at 
enrollment and at 24 hours. The enrollment curves were constructed 
to determine if there was any survival difference at day 28 for 
lactate >2 mmol//L and <2 mmol/L. Similarly, the threshold chosen 
for the PcvCO2–PaCO2/CaO2–CcvO2 ratio was >1  mm  Hg/mL/dL 
and <1 mm Hg/mL/dL. Both these thresholds were chosen as the 
upper limit of normal values for the lactate and the PcvCO2–PaCO2/
CaO2–CcvO2 ratio. There was no difference in the survival probability 
at enrollment for both the variables chosen. This is physiologically 
explicable again from the observation that the median lactate at 
enrollment in the study was below this threshold (1.8 mmol/L). The 
median PcvCO2–PaCO2/CaO2–CcvO2 ratio at enrollment was 1.759. 
Although this value was higher than 1.0, in the analysis between 
survivors and nonsurvivors, the median value of the PcvCO2–PaCO2/
CaO2–CcvO2 ratio at enrollment was not different between the 
two subgroups. The Kaplan–Meier survival curves at 24  hours 
were constructed using the thresholds with the best combination 
of sensitivity and specificity obtained from the ROC tables. It is 
also notable that the largest differences between survivors and 
nonsurvivors in terms of the PcvCO2–PaCO2/CaO2–CcvO2 ratio and 
the arterial lactate were at the 24-hour time point. The threshold 
for the PcvCO2–PaCO2/CaO2–CcvO2 ratio was 1.696, and that for 
lactate was 1.6  mmol/L. The Kaplan–Meier curves at 24 hours 
for these thresholds show a significant difference in the survival 
probability. This reinforces the general theme that in patients with 
sepsis-induced hypotension if resuscitation targets [lactate and the 
PcvCO2–PaCO2/CaO2–CcvO2 ratio in this case] are not attained even 
after 24 hours of resuscitation, the outcome is poor. Therefore, these 
thresholds may be used as resuscitation targets.
The study performed by Ospina-Tascon et al.7 demonstrated 
that the prognostic value afforded by lactate was enhanced by the 
PcvCO2–PaCO2/CaO2–CcvO2 ratio. The values of AU-ROC for the 
lactate and the PcvCO2–PaCO2/CaO2–CcvO2 ratio in our study are 
similar, including the sensitivity and specificity. This implies that 
the PcvCO2–PaCO2/CaO2–CcvO2 ratio can be reasonably used to 
estimate the presence of anaerobic metabolism and predict the 
outcome in lieu of the lactate. However, it is noticeable that these 
indicators become statistically significant predictors of mortality 
only by 24 hours of the onset of hypotension. One can therefore 
conclude that hypotension is a relatively early clinical event in 
sepsis, while derangements in lactate are a late event. 
Although not designed for evaluation of this difference, it is 
notable that 73% of patients had an abnormal PcvCO2–PaCO2/
CaO2–CcvO2 ratio, while only 46.67% of patients had abnormal 
lactate. At the 24-hour time point, the PcvCO2–PaCO2/CaO2–CcvO2 
ratio remained deranged in 78% of patients, while only 61% of 
patients had abnormal lactate (>2.0 mmol/L). If one were to look 
at lactate alone at the time of enrollment, more than 50% of 
patients in our study would not be classified as being in shock. We 
feel that it could be further explored whether the PcvCO2–PaCO2/
CaO2–CcvO2 ratio is a more sensitive indicator of tissue hypoxia 
than the arterial lactate.
looked at stepwise lactate and the PcvCO2–PaCO2/CaO2–CcvO2 ratio 
kinetics and studied correlation at each time point with predefined 
sampling intervals. 
There was a significant negative correlation between the 
lactate clearance and the PcvCO2–PaCO2/CaO2–CcvO2 ratio at only 
one time point (18 hours; p = −0.4448, p = 0.0138). This is probably 
because patients were resuscitated early during sepsis-induced 
hypotension, and therefore, the lactate levels were not severely 
elevated. The median lactate at enrollment was 1.8 mmol/L, and 
the median lactate at the end of 24 hours was 1.65 mmol/L. Only 
14 of the 30 patients (47%) had a serum lactate >2.0  mmol/L at 
enrollment. Therefore, the overall scope for lactate reduction in 
the study population was rather low. 
Mekontso-Dessap et  al.5 in their retrospective study on ICU 
patients divided them into those with a high (>2.0 mmol/L) and low 
lactate (<2.0 mmol/L). They too found good correlation between 
the PcvCO2–PaCO2/CaO2–CcvO2) ratio and the lactate (R =  0.57, 
p <0.0001). However, the time intervals of these measurements were 
not clearly defined. Mesquida et al.6 in their retrospective analysis 
of 35 patients explored the ability of the PcvCO2–PaCO2 gap and 
Fig. 3: Kaplan–Meier survival estimate for lactate >1.6  mmol/L at 
24 hours
Fig. 4: Kaplan–Meier survival estimate for PcvCO2–PaCO2/CaCO2–CcvO2 
ratio >1.696 mm Hg/mL at 24 hours
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and 85  mm  Hg thresholds. For every one-unit increase in the 
TW-MAP <65 mm Hg, the odds of inhospital mortality increased 
by 11.4%, the odds of acute kidney injury increased by 7.0%, 
and the odds of myocardial injury increased by 4.5%. Sampling 
intervals were initially half-hourly till stabilization of the MAP, 
for a maximum of 2  hours. This was done to capture the early 
changes in PcvCO2–PaCO2/CaCO2–CcvO2 ratio and see if these 
changes were reflected by the lactate concentrations. The results 
demonstrate that such a correlation does exist. However, there was 
no correlation with lactate clearance. We did not use a pulmonary 
artery catheter or other direct carbon monoxide monitoring 
devices. This is in line with our institutional practice. The study 
demonstrates the correlation between two important markers 
of tissue hypoxia without measuring CI. In resource-constrained 
settings like ours, keeping costs low is also important.
This study did have a few limitations. We used the definition 
of sepsis as per the Surviving Sepsis Campaign guidelines, 2012. 
The Surviving Sepsis Campaign guidelines 2016 were published 
after the finalization of the study design. The use of CO2 partial 
pressures instead of contents, as illustrated by Ospina-Tacson 
et  al.,8 is a potential shortcoming. However, considering the 
linearity of the CO2 dissociation curve and the simplicity of using 
values from a direct readout of the analyzer, it was felt that the use 
of pressures was an acceptable substitute. In an ideal setting, the 
cardiac output should have been measured and VO2 calculated. A 
correlation between the VO2 and the PcvCO2–PaCO2/CaO2–CcvO2 
ratio would be attractive. This is because the ultimate objective 
of any resuscitation protocol is to increase the VO2 and reduce 
anaerobic metabolism. Bedside POC US and echocardiography, 
although freely in use in our ICU, is not part of the written protocol. 
Key decisions in the study population (fluid administration and 
limitation, determination of the condition of the lung parenchyma, 
etc.) were taken using ultrasound. However, since these were 
done at the discretion of the treating clinician and performed 
in an unselected manner, we could not integrate them into the 
study protocol. The details of fluids received in the preceding 
24  hours and cumulative fluid balance were not known to the 
treating team. This, unfortunately, reflects the reality of practice 
in a large public hospital with no electronic monitoring records 
and inadequate staffing at the ward/ER level. Such records would 
have been invaluable both for the management of the patient and 
for the purposes of this study.
In conclusion, the PcvCO2–PaCO2/CaCO2–CcvO2 ratio and the 
lactate are positively correlated during the first 24 hours following 
active resuscitation from sepsis-induced hypotension. The PcvCO2–
PaCO2/CaCO2–CcvO2 ratio at 24  hours is significantly higher in 
nonsurvivors, and a threshold of 1.696 mm Hg/mL/dL for PcvCO2–
PaCO2/CaCO2–CcvO2 ratio at 24 hours significantly differentiates 
survivors from nonsurvivors. The PcvCO2-PaCO2/CaCO2–CcvO2 
ratio may be used as an end point of hemodynamic resuscitation 
from septic shock.
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The patient population in our study was relatively young 
(mean age 38.4 years). This is partly because of many patients with 
polytrauma being enrolled, which primarily affects the younger 
population. The median time between the onset of symptoms and 
hospitalization in our study was more than 36 hours. The median 
time between hospitalization and recruitment was 97 hours. These 
numbers have important implications. A longer time between 
symptom/event onset and hospital arrival signifies the possibility 
of physiological derangement that has progressed untreated. The 
time from hospitalization to recruitment is also long. This meant that 
most of the infections that these patients were hospital-acquired, 
which have a much higher mortality than community-acquired 
infections. It also implies that these episodes of sepsis are potentially 
not the first that the patients had. Repeated episodes of sepsis and 
septic shock have higher mortality than the first episode. This is an 
important distinction between our study and other studies that 
enrolled only patients with the first episode of sepsis.
In the present study, the key parameter for enrollment was the 
occurrence of hypotension due to sepsis (suspected or proven). 
We did not choose any other parameter because hypotension 
is the usual clinical marker for intervention, and resuscitation 
begins only after the recognition of the clinical marker. Making 
the entry criterion clinical would allow more ICUs and centers to 
test our hypothesis using the current methodology. We did not 
exclude patients based on the first episode of sepsis or the time 
since hospitalization. The sole criterion was direct observation 
of hypotension and initiation of resuscitation. If a marker of 
anaerobic metabolism must perform in clinical practice [the 
PcvCO2–PaCO2/CaO2–CcvO2 ratio in this case], it must be validated 
across patient categories and severity with minimal exceptions. 
We feel this reflects clinical reality, where unselected patients in 
the ICU develop hypotension and are resuscitated accordingly. The 
quantity of fluids administered in our patients in the first 3 hours 
of resuscitation is not in accordance with the surviving sepsis 
guidelines (30 mL/kg). The standard protocol in our institution 
is not to administer such a large quantity of fluids as a matter 
of routine. Our patients spent a considerable amount of time in 
the hospital on the general wards/ED before being transferred 
to the ICU. This has been alluded to before in this discussion. 
Consequently, they invariably receive intravenous crystalloids and 
are usually volume replete. This is different from other studies. In 
the study by Gustavo-Ospina et al.,8 patients received 1977 mL 
(1200–2800  mL) of fluids before the first sampling, which was 
3 hours after the first episode of hypotension. In our study, the 
interval between the onset of hypotension and the first sample 
was a maximum of 1 hour. This is because most of these patients 
already had a central venous catheter/intra-arterial catheter 
in situ or had these devices inserted almost immediately at the 
onset of hypotension. Our approach to hypotension in sepsis is 
the simultaneous use of fluids and vasopressors, without waiting 
for the completion of fluid boluses. Norepinephrine was the 
most common vasopressor used. Dobutamine was used at the 
discretion of the treating physician, either aimed at optimizing 
ScvO2 or in response to evidence of reduced cardiac contractility 
on bedside point-of-care ultrasound (POCUS). This strategy is to 
minimize the hypotensive period. The importance of minimizing 
the hypotensive duration was shown in a retrospective review 
of a large medical database by Maheshwari et al.9 In this study, 
hypotension exposure was defined by the time-weighted 
average MAP (TW-MAP) and cumulative time below 55, 65, 75, 
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